Genmab A/S
MONOCLONAL ANTIBODIES AGAINST C-MET
Last updated:
Abstract:
Isolated monoclonal antibodies which bind to human c-Met, the hepatocyte growth factor receptor, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
Status:
Application
Type:
Utility
Filling date:
23 Aug 2019
Issue date:
12 Mar 2020